Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15819804 | 0.84 | TNF (0.34) | TNF | |
| SCHEMBL15840579 | 0.78 | TNF (0.36) | TNF | |
| SCHEMBL15840581 | 0.75 | NR4A2 (0.34) | — | |
| SCHEMBL15840575 | 0.72 | CNR2 (0.34) | TNF | |
| SCHEMBL15819920 | 0.72 | NR4A2 (0.49) | ALDH1A1TNF | |
| SCHEMBL15840576 | 0.72 | PARP1 (0.38) | TNF | |
| SCHEMBL17278417 | 0.71 | TNF (0.34) | ALDH1A1TNF | |
| SCHEMBL28412876 | 0.68 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL15840577 | 0.67 | NCF1 (0.43) | ALDH1A1 | |
| SCHEMBL17278413 | 0.65 | TNF (0.36) | TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9604997-B2 | Peri-carbinols | ALDEYRA THERAPEUTICS, INC. (US) | 2017-03-28 | — | — | US | disclosed |
| US-9604997-B2 | Peri-carbinols | ALDEYRA THERAPEUTICS, INC. (US) | 2017-03-28 | — | — | US | disclosed |
| US-20150344432-A1 | PERI-CARBINOLS | Ricerca Biosciences, LLC | 2015-12-03 | — | — | US | disclosed |
| US-20150344432-A1 | PERI-CARBINOLS | Ricerca Biosciences, LLC | 2015-12-03 | — | — | US | disclosed |
| US-9005906-B2 | Tetrahydropyran nucleic acid analogs | ISIS PHARMACEUTICALS, INC. (US) | 2015-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344432-A1 | PERI-CARBINOLS | PLIN1, PLIN3, PLIN5 | PDPK1 1368/4885ALDH1A1 476/4885TNF 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.